In particular, noninvasive targeting imaging of early EGFR responses to medical therapy could indicate effectiveness, whereas particularly when tumor volume shrinkage is often delayed response to therapy using traditional extracellular space contrast agents [35]. Here, EGFR is linked to neoplasm.